STAAR Surgical Revenue vs. Current Valuation

STAA Stock  USD 26.68  0.05  0.19%   
Taking into consideration STAAR Surgical's profitability measurements, STAAR Surgical is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in December. Profitability indicators assess STAAR Surgical's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
1987-12-31
Previous Quarter
99 M
Current Value
88.6 M
Quarterly Volatility
20.4 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At present, STAAR Surgical's Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's EV To Sales is expected to grow to 18.87, whereas Days Sales Outstanding is forecasted to decline to 51.25. At present, STAAR Surgical's Operating Income is projected to increase significantly based on the last few years of reporting. The current year's Income Before Tax is expected to grow to about 35.4 M, whereas Accumulated Other Comprehensive Income is forecasted to decline to (4.3 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.480.7751
Way Down
Very volatile
For STAAR Surgical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of STAAR Surgical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well STAAR Surgical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between STAAR Surgical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of STAAR Surgical over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STAAR Surgical. If investors know STAAR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STAAR Surgical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.018
Earnings Share
0.44
Revenue Per Share
6.962
Quarterly Revenue Growth
0.103
Return On Assets
0.0339
The market value of STAAR Surgical is measured differently than its book value, which is the value of STAAR that is recorded on the company's balance sheet. Investors also form their own opinion of STAAR Surgical's value that differs from its market value or its book value, called intrinsic value, which is STAAR Surgical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STAAR Surgical's market value can be influenced by many factors that don't directly affect STAAR Surgical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STAAR Surgical's value and its price as these two are different measures arrived at by different means. Investors typically determine if STAAR Surgical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STAAR Surgical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

STAAR Surgical Current Valuation vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining STAAR Surgical's current stock value. Our valuation model uses many indicators to compare STAAR Surgical value to that of its competitors to determine the firm's financial worth.
STAAR Surgical is rated below average in revenue category among its peers. It also is rated below average in current valuation category among its peers reporting about  3.47  of Current Valuation per Revenue. At present, STAAR Surgical's Total Revenue is projected to increase significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the STAAR Surgical's earnings, one of the primary drivers of an investment's value.

STAAR Surgical's Earnings Breakdown by Geography

STAAR Revenue vs. Competition

STAAR Surgical is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 47.58 Billion. STAAR Surgical maintains roughly 322.42 Million in revenue contributing less than 1% to equities under Health Care industry.

STAAR Current Valuation vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

STAAR Surgical

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
322.42 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

STAAR Surgical

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
1.12 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

STAAR Current Valuation vs Competition

STAAR Surgical is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 225.63 Billion. STAAR Surgical adds roughly 1.12 Billion in current valuation claiming only tiny portion of equities under Health Care industry.

STAAR Surgical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in STAAR Surgical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, STAAR Surgical will eventually generate negative long term returns. The profitability progress is the general direction of STAAR Surgical's change in net profit over the period of time. It can combine multiple indicators of STAAR Surgical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-4.1 M-4.3 M
Operating Income28.1 M29.5 M
Income Before Tax33.7 M35.4 M
Total Other Income Expense Net5.6 M5.9 M
Net Income21.3 M22.4 M
Income Tax Expense12.3 M13 M
Net Income From Continuing Ops21.3 M22.4 M
Non Operating Income Net Other1.4 M1.5 M
Net Income Applicable To Common Shares44.6 M46.8 M
Interest Income214.2 K203.5 K
Net Interest IncomeM7.3 M
Change To Netincome24.5 M25.7 M
Net Income Per Share 0.58  0.61 
Income Quality 1.79  1.88 
Net Income Per E B T 0.88  1.13 

STAAR Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on STAAR Surgical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of STAAR Surgical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the STAAR Surgical's important profitability drivers and their relationship over time.

Use STAAR Surgical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if STAAR Surgical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STAAR Surgical will appreciate offsetting losses from the drop in the long position's value.

STAAR Surgical Pair Trading

STAAR Surgical Pair Trading Analysis

The ability to find closely correlated positions to STAAR Surgical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace STAAR Surgical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back STAAR Surgical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling STAAR Surgical to buy it.
The correlation of STAAR Surgical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as STAAR Surgical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if STAAR Surgical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for STAAR Surgical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your STAAR Surgical position

In addition to having STAAR Surgical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Non-Metallic and Industrial Metal Mining Thematic Idea Now

Non-Metallic and Industrial Metal Mining
Non-Metallic and Industrial Metal Mining Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Non-Metallic and Industrial Metal Mining theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Non-Metallic and Industrial Metal Mining Theme or any other thematic opportunities.
View All  Next Launch
When determining whether STAAR Surgical offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of STAAR Surgical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Staar Surgical Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Staar Surgical Stock:
Check out World Market Map.
For information on how to trade STAAR Stock refer to our How to Trade STAAR Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
To fully project STAAR Surgical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of STAAR Surgical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include STAAR Surgical's income statement, its balance sheet, and the statement of cash flows.
Potential STAAR Surgical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although STAAR Surgical investors may work on each financial statement separately, they are all related. The changes in STAAR Surgical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on STAAR Surgical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.